000
| 02038nam 2200361zi 4500 |
---|
001 | 9.923957 |
---|
003 | CaOODSP |
---|
005 | 20230821154517 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 230616s2022 onca o f000 0 eng d |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aCC273-3/8-2021E-PDF |
---|
245 | 00|aImpairment and the COVID-19 pandemic. |
---|
264 | 1|a[Ottawa] : |bCanadian Centre for Occupational Health and Safety, |c[2022] |
---|
300 | |a1 online resource (3 unnumbered pages) : |billustrations. |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
490 | 1 |a[COVID-19 health and safety resources] |
---|
500 | |aCaption title. |
---|
500 | |aIssued also in French under title: Facultés affaiblies et pandémie de COVID-19. |
---|
520 | |a"In Canada, the COVID-19 pandemic has created an unprecedented challenge that has changed the way that we live and work. One of the indirect impacts of the COVID-19 pandemic in Canada is a possible increase in the use of substances (e.g. the use of prescription drugs, alcohol, cannabis, illegal drugs) to cope with the stress of the pandemic. This document provides employers and employees with an introduction to workplace impairment, with a focus on substance use during the pandemic. General recommendations are outlined for implementing a workplace impairment program"--Introduction. |
---|
650 | 0|aCOVID-19 (Disease)|zCanada|xPsychological aspects. |
---|
650 | 0|aIndustrial hygiene|zCanada. |
---|
650 | 0|aSubstance abuse|zCanada. |
---|
710 | 2 |aCanadian Centre for Occupational Health and Safety, |eissuing body. |
---|
775 | 08|tFacultés affaiblies et pandémie de COVID-19.|w(CaOODSP)9.926322 |
---|
830 | #0|aCOVID-19 health and safety resources.|w(CaOODSP)9.923788 |
---|
856 | 40|qPDF|s125 KB|uhttps://publications.gc.ca/collections/collection_2023/cchst-ccohs/CC273-3-8-2021-eng.pdf |
---|
856 | 41|qHTML|sN/A|uhttps://www.ccohs.ca/covid19/impairment/ |
---|